Mol Pharm

From Bioblast
Revision as of 10:15, 20 July 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Journal |Title=[https://pubs.acs.org/journal/mpohbp Molecular Pharmaceutics] }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Journals in Bioblast
Journal title and website Molecular Pharmaceutics

Publications

 ReferencePublishedView
Pacheco-Velazquez 2018 Mol PharmPacheco-Velázquez SC, Robledo-Cadena DX, Hernández-Reséndiz I, Gallardo-Pérez JC, Moreno-Sánchez R, Rodríguez-Enríquez S (2018) Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 15:2151-64.2018PMID: 29746779
Paredes-Gamero 2012 Mol PharmParedes-Gamero EJ, Casaes-Rodrigues RL, Moura GE, Domingues TM, Buri MV, Ferreira VH, Trindade ES, Moreno-Ortega AJ, Cano-Abad MF, Nader HB, Ferreira AT, Miranda A, Justo GZ, Tersariol IL (2012) Cell-permeable gomesin peptide promotes cell death by intracellular Ca2+ overload. Mol Pharm 9:2686-97.2012PMID: 22873645
Retrieved from "https://wiki.oroboros.at/index.php?title=Mol_Pharm&oldid=159801"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
More information
Powered by MediaWiki
Powered by Semantic MediaWiki